Cerevel Therapeutics Holdings, Inc.Cerevel Therapeutics Holdings, Inc.Cerevel Therapeutics Holdings, Inc.

Cerevel Therapeutics Holdings, Inc.

No trades
See on Supercharts
Market capitalization
‪7.55 B‬USD
−2.67USD
‪−432.84 M‬USD
‪87.00 M‬
Beta (1Y)
1.43

About Cerevel Therapeutics Holdings, Inc.

CEO
Ronald C. Renaud
Headquarters
Cambridge
Employees (FY)
334
Founded
2018
ISIN
US15678U1280
FIGI
BBG00VCYVLH4
Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease. Its product candidates include CVL-231, Darigabat, Tavapadon, CVL-871, and CVL-936. The company was founded in 2018 and is headquartered in Cambridge, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CERE is 42.01 USD — it has increased by 0.97% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cerevel Therapeutics Holdings, Inc. stocks are traded under the ticker CERE.
Cerevel Therapeutics Holdings, Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
CERE stock is 1.01% volatile and has beta coefficient of 1.43. Check out the list of the most volatile stocks — is Cerevel Therapeutics Holdings, Inc. there?
One year price forecast for Cerevel Therapeutics Holdings, Inc. has a max estimate of 45.00 USD and a min estimate of 45.00 USD.
CERE earnings for the last quarter are −0.61 USD whereas the estimation was −0.63 USD which accounts for 2.74% surprise. Estimated earnings for the next quarter are −0.67 USD. See more details about Cerevel Therapeutics Holdings, Inc. earnings.
Yes, you can track Cerevel Therapeutics Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
CERE stock has fallen by 0.39% compared to the previous week, the month change is a 1.37% fall, over the last year Cerevel Therapeutics Holdings, Inc. has showed a 59.71% increase.
CERE net income for the last quarter is ‪−132.66 M‬ USD, while the quarter before that showed ‪−96.36 M‬ USD of net income which accounts for −37.67% change. Track more Cerevel Therapeutics Holdings, Inc. financial stats to get the full picture.
Today Cerevel Therapeutics Holdings, Inc. has the market capitalization of ‪7.55 B‬, it has decreased by 0.33% over the last week.
No, CERE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CERE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cerevel Therapeutics Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
CERE reached its all-time high on Nov 8, 2021 with the price of 46.16 USD, and its all-time low was 9.00 USD and was reached on Oct 28, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 334.00 employees. See our rating of the largest employees — is Cerevel Therapeutics Holdings, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cerevel Therapeutics Holdings, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cerevel Therapeutics Holdings, Inc. stock shows the buy signal. See more of Cerevel Therapeutics Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Cerevel Therapeutics Holdings, Inc. future price: according to them, CERE price has a max estimate of 45.00 USD and a min estimate of 45.00 USD. Read a more detailed Cerevel Therapeutics Holdings, Inc. forecast: see what analysts think of Cerevel Therapeutics Holdings, Inc. and suggest that you do with its stocks.